The Beauty Health Company
Beauty / aesthetic devicesUSA
📉 Public < $1B
Peak $4 BillionToday
~-96%
from peak
- 🦄Became a unicorn2021
- 📈Peak valuation$4 Billion ’21
- 💔Became a Unitard2022
- 💸Last valuation~$160M
Current status
Public (Nasdaq: SKIN); market cap ~$0.15B, down ~96% from its 2021 peak.
How it happened
The Beauty Health Company makes Hydrafacial, the popular facial-treatment system sold to spas and dermatology clinics, along with other aesthetic devices. It went public in May 2021 via a SPAC merger with Brent Saunders' Vesper Healthcare Acquisition Corp, and its stock soared to lift its market value to roughly $4B by late 2021. A device-sales slump, recalls and a cooling aesthetics market then crushed it; the stock fell about 96%, leaving Beauty Health worth around $150M — a fraction of its peak.
Source: stockanalysis / PitchBook / SEC (SPAC merger with Vesper Healthcare Acquisition Corp May 2021; ATH ~$28 late 2021 (~$4B); ~$147M market cap by 2026, -96%; device sales slumped)
